Alzheimer’s disease develops from a combination of age, genetics, and lifestyle factors that interact over decades, not from a single cause. About 1 in 9 Americans over 65 have it, and 74% of those affected are 75 or older. The disease begins in the brain long before symptoms appear, with toxic proteins accumulating silently for 15 to 20 years before memory loss becomes noticeable.
What Happens Inside the Brain
Alzheimer’s starts with two proteins going wrong. The first is amyloid-beta, a small fragment snipped from a larger protein on nerve cell surfaces. Normally these fragments are cleared away. In Alzheimer’s, they clump together into sticky clusters called plaques that build up between brain cells. These clumps begin as small, soluble clusters and eventually form dense, insoluble deposits that disrupt communication between neurons.
The second protein is tau. In a healthy brain, tau acts like railroad ties holding the internal tracks of a nerve cell together, giving the cell its structure and allowing nutrients to travel where they need to go. In Alzheimer’s, tau becomes heavily modified and detaches from these internal tracks. The loose tau molecules tangle together into knotted fibers inside the cell, collapsing the transport system and eventually killing the neuron.
These two processes feed each other. Amyloid buildup appears to trigger the spread of tau tangles into new brain regions, and together they set off a cascade of damage that slowly erodes memory, reasoning, and eventually basic body functions.
The Brain’s Immune System Turns Against Itself
The brain has its own immune cells, called microglia, that normally patrol for threats and clean up debris. When amyloid plaques first appear, microglia rush to the site and try to engulf them. In the short term, this helps. But when plaques keep accumulating and the immune response never shuts off, these cells shift from protective to destructive.
Chronically activated microglia release inflammatory molecules that damage nearby neurons and strip away synapses, the connection points between brain cells. They also appear to actively spread tau tangles from one brain region to another by swallowing tau-containing debris and releasing it elsewhere. Studies in animal models show that depleting microglia slows the spread of tau pathology, confirming their role in accelerating the disease. Over time, microglia also trigger changes in other support cells in the brain, reducing their ability to nourish neurons and clear waste. This creates a self-reinforcing cycle: more inflammation, more damage, more inflammation.
Genetics and the APOE-e4 Gene
The single strongest genetic risk factor for the common, late-onset form of Alzheimer’s is a gene variant called APOE-e4. Between 15% and 25% of people carry one copy of this variant. Carrying one copy raises your risk and tends to push the age of onset earlier. Carrying two copies, which occurs in 2% to 5% of the population, raises risk substantially more. But APOE-e4 is not destiny. Some people with two copies never develop the disease, and many people who get Alzheimer’s carry no copies at all.
A much rarer form, early-onset familial Alzheimer’s, strikes before age 65 and is caused by mutations in one of three specific genes: PSEN1, PSEN2, or APP. These mutations follow an autosomal dominant inheritance pattern, meaning a child of someone with the mutation has a 50% chance of inheriting it. People who do inherit it will almost certainly develop the disease, often in their 40s or 50s. This form accounts for a small fraction of all Alzheimer’s cases.
How Insulin Resistance Affects the Brain
The brain depends heavily on insulin, not just for energy metabolism but for maintaining the connections between neurons. Insulin helps form new synapses, supports the turnover of chemical messengers, and plays a direct role in clearing amyloid-beta from the brain and regulating tau. When brain cells become resistant to insulin, all of these processes falter simultaneously.
Type 2 diabetes and prediabetes are well-established risk factors for Alzheimer’s, and the overlap is so significant that some researchers have informally called Alzheimer’s “type 3 diabetes.” Insulin resistance also affects blood vessel function in the brain, altering blood flow, fat metabolism, and inflammation. The combined effect is that neurons lose energy, accumulate more toxic protein, and die faster.
Sleep and Brain Waste Clearance
During deep sleep, the spaces between brain cells expand by roughly 60%, allowing cerebrospinal fluid to flush through brain tissue and carry away metabolic waste, including amyloid-beta. This drainage network, sometimes called the glymphatic system, is most active during sleep and largely shuts down while you’re awake.
Chronic sleep deprivation or disrupted sleep means less time for this cleaning process. Over years and decades, the reduced clearance may allow amyloid to accumulate faster than it otherwise would. People with sleep apnea, chronic insomnia, and irregular sleep schedules show higher rates of amyloid buildup even before any cognitive symptoms appear.
Cardiovascular and Metabolic Risk Factors
What’s bad for your heart tends to be bad for your brain. High blood pressure in midlife, high cholesterol, obesity, smoking, and physical inactivity all increase the risk of developing Alzheimer’s later in life. The brain consumes about 20% of the body’s blood supply, so anything that damages blood vessels or reduces blood flow has outsized consequences there.
Damaged blood vessels in the brain can impair the delivery of oxygen and nutrients to neurons, accelerate amyloid deposition, and trigger inflammation. Many Alzheimer’s patients have a mix of classic Alzheimer’s pathology and vascular damage, and the two reinforce each other.
Air Pollution and Environmental Exposures
Long-term exposure to fine particulate air pollution (PM2.5) is an emerging risk factor. A large national cohort study in the United States found that a moderate increase in PM2.5 exposure was associated with a 9% increase in Alzheimer’s incidence. Black carbon, a component of traffic exhaust and industrial emissions, showed an even stronger link: each 1 microgram per cubic meter increase was associated with a 23% higher risk of Alzheimer’s. Fine particles are small enough to cross from the lungs into the bloodstream and potentially into the brain, where they may trigger inflammation and oxidative damage.
Oral Health and Brain Infection
A bacterium responsible for chronic gum disease, P. gingivalis, has been found in the brains and spinal cords of Alzheimer’s patients. Animal studies show that oral infection with this bacterium leads to brain colonization and increased production of amyloid-beta. The bacterium produces enzymes called gingipains that may also stimulate increased tau production. This doesn’t mean gum disease causes Alzheimer’s on its own, but chronic oral infection appears to be one more factor that can push the brain toward disease, likely through sustained low-grade inflammation and direct bacterial invasion along nerve pathways.
Cognitive Reserve: Why Education and Activity Matter
People with more years of formal education, more complex occupations, and more mentally stimulating leisure activities tend to develop Alzheimer’s symptoms later, even when their brains show the same amount of pathology as someone already experiencing dementia. This concept is called cognitive reserve. Essentially, a brain that has built more neural connections over a lifetime has more backup pathways available when some connections are destroyed by disease.
This doesn’t prevent the underlying biology. At higher levels of pathology, people with greater cognitive reserve still decline. But they may gain years of normal functioning that someone with lower reserve would not have. The practical implication is that staying mentally and socially engaged throughout life appears to delay the point at which Alzheimer’s pathology translates into noticeable symptoms.
Why Age Is the Biggest Factor
Despite all of these contributing causes, age remains the single most powerful risk factor. Alzheimer’s is rare before 65 and rises sharply after 75. This isn’t because aging “causes” Alzheimer’s, but because the brain’s ability to clear toxic proteins, repair damaged DNA, manage inflammation, and maintain blood flow all decline with age. Each of the risk factors described above interacts with aging: a genetic vulnerability that was manageable at 50 may become unmanageable at 80 as the brain’s compensatory systems weaken. The disease is best understood not as one thing going wrong, but as multiple systems gradually failing to keep the brain clean, connected, and nourished over the course of a long life.